Specialty pharmaceutical company focused on the treatment of OFF episodes in Parkinson’s disease
Location: Canada, Ontario, Toronto
Total raised: $72.5M
Investors 1
| Date | Name | Website |
| - | Aisling Ca... | aislingcap... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.06.2015 | - | $72.5M | - |
Mentions in press and media 2
| Date | Title | Description |
| 23.06.2015 | Cynapsus Therapeutics Inc. Closes US$72.5 Million Public Offering of Common Shares in the United States | TORONTO, ONTARIO – (Marketwired) – Cynapsus Therapeutics Inc. (NASDAQ: CYNA) (TSX: CTH) (the “Company” or “Cynapsus”) announced today that it has completed its previously announced underwritten public offering in the United States (the “Off... |
| 18.06.2015 | Cynapsus Therapeutics Inc. Announces Pricing of US$63.0 Million Public Offering of Common Shares in the United States | TORONTO, ONTARIO — Cynapsus Therapeutics Inc. (TSX:CTH)(OTCQX:CYNAD) (the “Company” or “Cynapsus”) announced today the pricing of its underwritten public offering in the United States of 4,500,000 common shares at a price to the public of U... |